Skip to main content
SpringerLink
Log in

Progesterone rise on the day of HCG administration (premature luteinization) in IVF: An overdue update

  • EXPERIMENTAL ASSISTED REPRODUCTION
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Premature luteinization (PL) refers to a rise in serum progesterone (P) levels on the day of hCG administration. Most studies used an absolute P level on the day of hCG administration as an indicator of PL, and the cutoff level differed from 0.8 to 2 ng/mL. Some authors defined PL as a P/E2 ratio of >1. There is a marked variation in the incidence (13% to 71%), of PL due to discrepancies in definition, population characteristics and/or treatment protocols. The pathogenesis of PL in COH is still poorly understood. Several hypotheses may be considered to explain this phenomenon: elevation of follicular LH levels, serum accumulation of HCG from HMG, increased LH receptor sensitivity of the granulosa cells to FSH, or poor ovarian response with increased LH sensitivity. The consequences of this premature elevation of serum P on IVF outcome remain controversial. Attempts to prevent COH include: use of Low-dose hCG alone in the late COH stages, flexible antagonist protocol, use of mifepristone, aspiration of a single leading follicle, hCG administration when the levels of serum P exceeded 1.0 ng/mL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smitz J, Ron-El R, Tarlatzis BC. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod. 1992;7:49–66.

    PubMed  Google Scholar 

  2. Hofmann GE, Bentzien F, Bergh PA, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 1993;60:675–9.

    CAS  PubMed  Google Scholar 

  3. Legro RS, Ary BA, Paulson RJ, et al. Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum Reprod. 1993;8:1506–11.

    CAS  PubMed  Google Scholar 

  4. Ubaldi F, Albano C, Peukert M, et al. Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod. 1996;11:1405–7.

    CAS  PubMed  Google Scholar 

  5. Bosch E, Valencia I, Escudero E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80:1444–9.

    Article  PubMed  Google Scholar 

  6. Venetis C, Kolibianakis E, Papanikolaou E, Bontis J, Devroey P, Tarlatzis B. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update. 2007;13:343–55.

    Article  CAS  PubMed  Google Scholar 

  7. Silverberg KM, Martin M, Olive DL, et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality. Fertil Steril. 1994;61:508–13.

    CAS  PubMed  Google Scholar 

  8. Fanchin R, de Ziegler D, Taieb J, et al. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril. 1993;59:1090–4.

    CAS  PubMed  Google Scholar 

  9. Harada T, Yoshida S, Katagiri C, et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod. 1995;10:1060–4.

    CAS  PubMed  Google Scholar 

  10. Hofmann GE, Khoury J, Johnson CA, et al. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization embryo transfer has no impact on pregnancy outcome. Fertil Steril. 1996;66:980–6.

    CAS  PubMed  Google Scholar 

  11. Edelstein MC, Seltman HJ, Cox BJ, et al. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril. 1990;54:853–7.

    CAS  PubMed  Google Scholar 

  12. Check JH, Chase JS, Nowroozi K, Dietterich CJ. Premature luteinization: treatment and incidence in natural cycles. Hum Reprod. 1991;6:190–3.

    CAS  PubMed  Google Scholar 

  13. Givens CR, Schriock ED, Dandekar PV, et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril. 1994;62:1011–7.

    CAS  PubMed  Google Scholar 

  14. Ou YC, Lan KC, Chang SY, Kung FT, Huang FJ. Increased progesterone/estradiol ratio on the Day of hcg administration adversely affects Success of in vitro fertilization–embryo Transfer in patients stimulated with Gonadotropin-releasing hormone agonist and Recombinant follicle-stimulating hormone Taiwan. J Obstet Gynecol. 2008;47:168–74.

    Google Scholar 

  15. Younis JS, Simon A, Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril. 1996;66:873–84.

    CAS  PubMed  Google Scholar 

  16. Hamori M, Stuckensen JA, Rumpf D, Kniewald T, Kniewald A, Kurtz CS. Premature luteinization of follicles during ovarian stimulation of in vitro fertilisation. Hum Reprod. 1987;2:639–43.

    CAS  PubMed  Google Scholar 

  17. Martinez F, Coroleu B, Clua E, et al. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online. 2004;8:183–90.

    Article  CAS  PubMed  Google Scholar 

  18. Ubaldi F, Smitz J, Wisanto A, et al. Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod. 1995;10:3091–6.

    Article  CAS  PubMed  Google Scholar 

  19. Seow KM, Lin YH, Huang LW, Hsieh BC, Huang SC, Chen CY, et al. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles. Gynecol Endocrinol. 2007;23:338–42.

    Article  CAS  PubMed  Google Scholar 

  20. Sims A, Seltman HJ, Muasher SJ. Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization. Hum Reprod. 1994;9:235–40.

    CAS  PubMed  Google Scholar 

  21. Ron-El R. Improved pregnancy rate in IVF/ET by combined long-acting GnRH analogue and gonadotropins. In: Vickery BH, Lunenfeld B, editors. GnRH analogues in reproduction and gynecology, vol. II. Dordrecht: Kluwer Academic; 1990. p. 167–71.

    Google Scholar 

  22. Penzias AS, Shamma FN, Gutmann JN, Jones EE, DeCherney AH, Lavy G. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial. Obstet Gynecol. 1992;79:739–42.

    CAS  PubMed  Google Scholar 

  23. Copperman AB, Horowitz GM, Kaplan P, Scott RT, Navot D, Hofmann GE. Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil Steril. 1995;63:1267–71.

    CAS  PubMed  Google Scholar 

  24. Stokman PGW, de Leeuw R, van den Wijngaard HAGW, Kloosterboer HJ, Vemer HM, Sanders ALM. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril. 1993;60:175–8.

    CAS  PubMed  Google Scholar 

  25. Mannaerts B, de Leeuw R, Geelen J, Van Ravestein A, Van Wezenbeek P, Schuurs A, et al. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology. 1991;129:2623–30.

    Article  CAS  PubMed  Google Scholar 

  26. Shaw RW, Ndukwe G, Imoedemhe DA, Bernard AG, Burford G. Twin pregnancy after pituitary desensitization with LHRH agonist and pure FSH. Lancet. 1985;326:506–7.

    Article  Google Scholar 

  27. Peluso JJ. Role of the amplitude of the gonadotropin surge in the rat. Fertil Steril. 1990;53:150–4.

    CAS  PubMed  Google Scholar 

  28. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborrelli S, et al. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod. 2002;17:2009–15.

    Article  CAS  PubMed  Google Scholar 

  29. Adonakis G, Deshpande N, Yates RWS, Fleming R. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle stimulating hormone. Fertil Steril. 1998;69:450–3.

    Article  CAS  PubMed  Google Scholar 

  30. Younis JS, Matilsky M, Radin O, Ben-Ami M. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin releasing hormone agonist. Fertil Steril. 2001;76:294–9.

    Article  CAS  PubMed  Google Scholar 

  31. Chand L, Ponnampalam P, Harris E, Winship M, Shelling N. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril. 2006;86:1009–12.

    Article  CAS  PubMed  Google Scholar 

  32. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, Cavallo L, et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab. 2006;91:1976–9.

    Article  PubMed  CAS  Google Scholar 

  33. Juengel L, McNatty P. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update. 2005;11:143–60.

    CAS  PubMed  Google Scholar 

  34. Pangas S, Li X, Robertson E, Matzuk M. Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. Mol Endocrinol. 2006;20:1406–22.

    Article  CAS  PubMed  Google Scholar 

  35. Fanchin R, Hourvitz A, et al. Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture. Fertil Steril. 1997;68:648–52.

    Article  CAS  PubMed  Google Scholar 

  36. Shulman A, Ghetler Y, Beyth Y, et al. The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a “long protocol” of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J Assist Reprod Genet. 1996;13:207–11.

    Article  CAS  PubMed  Google Scholar 

  37. Howles CM, Macnamee MC, Edwards RG. Progesterone supplementation in the late follicular phase of an in vitro fertilisation cycle: a natural way to time oocyte recovery? Hum Reprod. 1988;3:409–12.

    CAS  PubMed  Google Scholar 

  38. Mahadevan MM, Fleetham J, Taylor PJ. Effects of progesterone on luteinizing hormone release and estradiol/progesterone ratio in the luteal phase of women superovulated for in vitro fertilisation and embryo transfer. Fertil Steril. 1988;50:935–7.

    CAS  PubMed  Google Scholar 

  39. Ben-Nun I, Ghetler Y, Jaffe R, Siegal A, Kaneti H, Fejgin M. The effect of preovulatory progesterone administration on the endometrial maturation and implantation rate after in vitro fertilisation and embryo transfer. Fertil Steril. 1990;53:276–81.

    CAS  PubMed  Google Scholar 

  40. Hassiakos D, Toner JP, Muasher SJ, Jones HW. Implantation and progesterone profiles in cycles with and without the use of gonadotropin releasing hormone agonist suppression. Hum Reprod. 1990;5:1004–8.

    CAS  PubMed  Google Scholar 

  41. Silverberg KM, Burns WN, Olive DL, et al. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab. 1991;73:797–803.

    Article  CAS  PubMed  Google Scholar 

  42. Antoine JM, Firmin C, Salat-Baroux J, et al. Prognostic value of preovulatory elevations of plasma progesterone during in vitro fertilization using LHRH agonists in a long protocol. J Gynecol Obstet Biol Reprod. 1992;21:629–34.

    CAS  Google Scholar 

  43. Bustillo M, Stern JJ, Coulam CB. Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer. Hum Reprod. 1995;10:2862–7.

    CAS  PubMed  Google Scholar 

  44. Levy MJ, Smotrich DB, Widra EA, et al. The predictive value of serum progesterone and 17-OH progesterone levels on in vitro fertilization outcome. J Assist Reprod Genet. 1995;12:161–6.

    Article  CAS  PubMed  Google Scholar 

  45. Abuzeid MI, Sasy MA. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil Steril. 1996;65:981–5.

    CAS  PubMed  Google Scholar 

  46. Huang JC, Jackson KV, Hornstein MD, et al. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer. J Assist Reprod Genet. 1996;13:617–24.

    Article  CAS  PubMed  Google Scholar 

  47. Miller KF, Behnke EJ, Arciaga RL, et al. The significance of elevated progesterone at the time of administration of human chorionic gonadotropin may be related to luteal support. J Assist Reprod Genet. 1996;13:698–701.

    Article  CAS  PubMed  Google Scholar 

  48. Moffitt DV, Queenan Jr JT, Shaw R. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. Fertil Steril. 1997;67:296–301.

    Article  CAS  PubMed  Google Scholar 

  49. Doldi N, Marsiglio E, Destefani A, et al. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod. 1999;14:601–5.

    Article  CAS  PubMed  Google Scholar 

  50. Lindheim SR, Cohen MA, Chang PL, et al. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization—embryo transfer cycles. J Assist Reprod Genet. 1999;16:242–6.

    Article  CAS  PubMed  Google Scholar 

  51. Urman B, Alatas C, Aksoy S, et al. Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer. Fertil Steril. 1999;72:975–9.

    Article  CAS  PubMed  Google Scholar 

  52. Schoolcraft W, Sinton E, Schlenker T, et al. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril. 1991;55:563–6.

    CAS  PubMed  Google Scholar 

  53. Kagawa T, Yamano S, Nishida S, et al. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF–ET). J Assist Reprod Genet. 1992;9:106–12.

    Article  CAS  PubMed  Google Scholar 

  54. Mio Y, Sekijima A, Iwabe T, et al. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril. 1992;58:159–66.

    CAS  PubMed  Google Scholar 

  55. Mio Y, Terakawa N. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod. 1995;10:1060–4.

    PubMed  Google Scholar 

  56. Ozcakir HT, Levi R, Tavmergen E, Goker EN. Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles. J Obstet Gynaecol Res. 2004;30:100–4.

    Article  CAS  PubMed  Google Scholar 

  57. Fanchimont P, Hazee-Hagelstein MT, Hazout A, Frydman R, Scatz B, Demerle F. Correlation between follicular fluid content and the results of in vitro fertilisation and embryo transfer. Fertil Steril. 1989;52:1006–11.

    Google Scholar 

  58. Yovel I, Yaron Y, Amit A, et al. High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil Steril. 1995;64:128–31.

    CAS  PubMed  Google Scholar 

  59. Fanchin R, Righini C, Olivennes F, et al. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril. 1996;65:1178–83.

    CAS  PubMed  Google Scholar 

  60. Garcia JE, Acosta AA, Hsiu JG, Jones HW. Advanced endometrial maturation after ovulation induction with human menopausal gonadotrophin/ human chorionic gonadotrophin for in vitro fertilisation. Fertil Steril. 1984;41:31–5.

    CAS  PubMed  Google Scholar 

  61. Forman RG, Eychenne B, Nessmann C, Frydman R, Robel P. Assessing the early luteal phase in vitro fertilisation cycles: relationships between plasma steroids, endometrial receptors, and endometrial histology. Fertil Steril. 1989;51:310–6.

    CAS  PubMed  Google Scholar 

  62. Sharma V, Whitehead M, Mason B, Pryse-Davies J, Ryder T, Dowsett M, et al. Influence of superovulation on endometrial and embryonic development. Fertil Steril. 1990;53:822–9.

    CAS  PubMed  Google Scholar 

  63. Burns WN, Witz CA, Klein NA, Silverberg KM, Schnken RS. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilisation/ embryo transfer outcome. J Assist Reprod Genet. 1994;11:17–23.

    Article  CAS  PubMed  Google Scholar 

  64. Melo M, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohí J. The significance of premature luteinization in an oocyte-donation programme. Hum Reprod. 2006;21:1503–7.

    Article  CAS  PubMed  Google Scholar 

  65. Bosch E. Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007). Hum Reprod Update. 2008;14:194–5.

    Article  CAS  PubMed  Google Scholar 

  66. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril. 2005;84:394–401.

    Article  PubMed  CAS  Google Scholar 

  67. Lainas T, Zorzovilis J, Petsas G, Stavropoulou G, Cazlaris H, Daskalaki V, et al. In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF. Hum Reprod. 2005;20:2426–33.

    Article  CAS  PubMed  Google Scholar 

  68. Escudero EL, Boerrigter PJ, Bennink HJ, Epifanio R, Horcajadas JA, Olivennes F, et al. Mifepristone is an effective oral alternative for the prevention of premature luteinizing hormone surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2005;90:2081–8.

    Article  CAS  PubMed  Google Scholar 

  69. Harada T, Katagiri C, Takao N, Toda T, Mio Y, Terakawa N. Altering the timing of human chorionic gonadotropin injection according to serum progesterone concentrations improves embryo quality in cycles with subtle P rise. Fertil Steril. 1996;65:594–7.

    CAS  PubMed  Google Scholar 

  70. Barash A, Shoham Z, Lunenfeld B, Segal I, Insler V, Borenstein R. Can premature luteinization in superovulation protocols be prevented by aspiration of an ill-timed leading follicle? Fertil Steril. 1990;53:865–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Benha University, Benha, Egypt

    Aboubakr M. Elnashar

Authors
  1. Aboubakr M. Elnashar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aboubakr M. Elnashar.

Additional information

Capsule

Pathogenesis of premature luteinization is poorly understood and its impact on ICSI is controversial.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elnashar, A.M. Progesterone rise on the day of HCG administration (premature luteinization) in IVF: An overdue update. J Assist Reprod Genet 27, 149–155 (2010). https://doi.org/10.1007/s10815-010-9393-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-010-9393-8

Keywords

Search

Navigation